呼吸器感染症におけるAmikacin (B8-K8) の臨床的研究

志摩 清; 徳永 勝正; 福田 安嗣; 浜田 和裕; 今村 正文; 弘 雍正; 賀来 隆二; 勝田 和夫; 赤塚 護

doi:10.11250/chemotherapy1953.23.2128

A STUDY OF AMIKACIN (BB-K8) ON THE CLINICAL EFFECTS ON THE RESPIRATORY INFECTION

KIYOSHI SHIMA, KATSUMASA TOKUNAGA, YASUTSUGU FUKUDA, KAZUHIRO HAMADA, MASABUMI IMAMURA, YOSEI HIRO, RYUJI KAKU, KAZUHIRO KATSUDA, MAMORU AKATSUKA

Author information

KIYOSHI SHIMA
First Department of Internal Medicine, Kumamoto Medical School, Kumamoto University
KATSUMASA TOKUNAGA
First Department of Internal Medicine, Kumamoto Medical School, Kumamoto University
YASUTSUGU FUKUDA
First Department of Internal Medicine, Kumamoto Medical School, Kumamoto University
KAZUHIRO HAMADA
First Department of Internal Medicine, Kumamoto Medical School, Kumamoto University
MASABUMI IMAMURA
First Department of Internal Medicine, Kumamoto Medical School, Kumamoto University
YOSEI HIRO
Toyofukuen, National Sanatorium
RYUJI KAKU
Minamata City Hospital
KAZUHIRO KATSUDA
Yamaga City Hospital
MAMORU AKATSUKA
Yamaga City Hospital

JOURNAL FREE ACCESS

1975 Volume 23 Issue 6 Pages 2128-2130

DOI https://doi.org/10.11250/chemotherapy1953.23.2128

Details

Abstract

Amikacin was used to 10 cases of respiratory diseases : 4 pulmonary abscess, 2 bronchiectasis, 2 bronchopneumonia, and 2 bronchitis. Clinical effects of amikacin were as follows : Two of four pulmonary abscess were effective, one slightly effective and one unchanged. Two bronchiectasis were effective. One of two bronchopneumonia was effective and one slightly effective. One of bronchitis was markedly effective and one effective. As the results, clinical effective rate was 90 percent. Side effects of amikacin were not experienced.

Corresponding author

Register with J-STAGE for free!